Aerosol Products

Powder Spray Testing for Dry Powder Products

Particle sizing, plume imaging, inhalation exposure assessment, and stability support for powder sprays and dry powder products.

ARE Labs measures airborne powder behavior under defined use conditions to support formulation, packaging, exposure, and documentation decisions.

ISO 17025ISO 13320OSHA PEL / NIOSH RELICH Q1A (R2)Reviewed 2026-05-17
Request a quoteSubmit a sample

Testing powder spray and dry powder products

Powder spray and dry powder product testing shows how formulation, powder grade, applicator geometry, package state, and use conditions affect measurable airborne behavior. Depending on the study question, programs may draw from ISO 13320, OSHA and NIOSH exposure frameworks, FDA inhalation guidance, or ICH Q1A (R2). These references help shape studies focused on particle size, plume behavior, inhalation exposure, or changes during storage. Programs are usually scoped when:

  1. ISO 13320 particle sizing compares powder grades, actuators, and moisture states when respirable fraction or settling behavior affects product decisions.
  2. ICH Q9 investigation framing supports high-speed imaging of clogging, sputtering, plume direction, and transient powder release from applicators.
  3. OSHA PEL or NIOSH REL exposure comparisons use chamber concentration and PSD inputs to evaluate consumer or workplace powder use scenarios.
  4. ICH Q1A (R2) stability pulls track caking, agglomeration, emitted cloud behavior, PSD drift, and package effects after storage.
  5. FDA MDI / DPI guidance context applies when a dry powder product is drug-like and needs aerodynamic sizing or emitted-output support.

Use this testing when formulation specifications alone cannot predict powder output, airborne fraction, plume repeatability, caking, or exposure. Before samples arrive, a defined protocol establishes powder handling, actuation, conditioning, sampling geometry, controls, and reporting endpoints.

Core testing menu for powder spray products

Powder spray programs often combine particle sizing, transient imaging, exposure assessment, and storage pulls. The appropriate test set depends on the product claim, use scenario, and whether the powder is a consumer, industrial, or drug-like product.

Test method options

MethodStrengthsTradeoffAligned with
Dry powder particle size and respirable fraction screen
  • Laser diffraction or APS data compare powder grade, applicator, conditioning, and airborne fraction under ISO 13320.
  • Respirable fraction outputs support FDA-style inhalation review and OSHA or NIOSH exposure-model inputs.
Dispersion energy and humidity must be controlled before formulation comparisons are meaningful.
ISO 13320FDA MDI / DPI / nasalOSHA PEL / NIOSH REL
Transient powder plume imaging
  • High-speed capture documents clogging, sputtering, plume direction, pulse duration, and powder-cloud breakup under ICH Q9.
  • Frame-by-frame timing separates applicator effects from powder flowability and handling effects.
Imaging describes visible release behavior; pair with PSD or recovery when mass or exposure drives the claim.
ICH Q9
Inhalation exposure assessment
  • Chamber sampling, PSD, and concentration-time data estimate powder exposure against OSHA PEL or NIOSH REL benchmarks.
  • Use-scenario assumptions identify whether particle size, release rate, room volume, or duration drives margin of safety.
This supports exposure review; it does not replace complete toxicology, labeling, or product certification.
OSHA PEL / NIOSH REL
Stability and conditioning performance pulls
  • ICH Q1A (R2) storage pulls track PSD drift, caking, plume behavior, package effects, and recovered active or tracer.
  • Trend tables support shelf-life, formulation, package, and storage-condition decisions.
Study duration follows the storage plan and pull schedule; endpoints should be locked before conditioning begins.
ICH Q1A (R2)
Drug-like dry powder output support
  • Cascade or aerodynamic sizing can support dry powder products when FDA MDI / DPI expectations apply by product intent.
  • Paired assay or tracer recovery connects emitted powder behavior to active-specific output where chemistry is required.
Broader CMC, clinical, biocompatibility, labeling, and full submission work remain outside this device page.
FDA MDI / DPI / nasal

Setup configurations

ARE Labs configures each powder spray study around the powder state, package design, use mode, and decision the data must support. Before testing begins, the protocol defines conditioning, handling, actuation, dispersion energy, sampling geometry, exposure scenario, analytical endpoint, controls, and replicate structure. This allows the measured powder behavior to be interpreted against the product requirement or safety question.

Powder and package state

Powder grade, moisture history, fill level, package model, applicator geometry, nozzle state, storage age, and handling instructions documented per condition.

Flow & actuation profiles

Squeeze, pump, airflow, gravity-feed, or custom actuation with force, duration, orientation, discharge count, and rest interval defined by protocol.

Sampling geometry

Chambers, mannequins, breathing-zone probes, filters, impactors, particle counters, or imaging views selected for the intended use scenario.

Environmental controls

Temperature, RH, preconditioning, static-control notes, background aerosol, and post-storage handling recorded when powder flow or agglomeration may shift.

Sample numbers

Product count, powder lots, replicate runs, conditioning pulls, blanks, and controls are sized during protocol development from variability and endpoint sensitivity.

Quality frame for dry powder testing

Powder spray studies distinguish the laboratory's accredited quality anchor from aligned references for particle sizing, exposure, and stability. Each chip corresponds to the accreditation row shown in the hero section of this page.

  • ISO 17025AccreditedLaboratory competence, traceability, method control, and uncertainty contributors.
  • ISO 13320AlignedLaser diffraction principles for dry powder particle sizing.
  • OSHA PEL / NIOSH RELAlignedExposure benchmarks for inhalation assessment where applicable.
  • ICH Q1A (R2)AlignedStorage-condition and trend logic for stability pulls.

Key data outputs & reporting

Powder spray programs produce endpoint-specific datasets that connect powder state and applicator setup with measured airborne behavior. Reports can support formulation screening, package comparisons, inhalation exposure review, complaint investigations, stability trending, or regulatory documentation. When storage drift, exposure modeling, or comparator interpretation is part of the study, extended deliverables provide the necessary pull-point and scenario context.

Primary outputs

  • PSD curves, Dv10/Dv50/Dv90 where applicable, aerodynamic fractions, respirable fraction estimates, and concentration-time profiles.
  • High-speed image sequences, discharge timing, visible clogging observations, plume direction, cloud duration, and setup photos.
  • Recovered powder mass, active or tracer recovery, chamber concentration by location, exposure-model inputs, and margin-of-safety tables.
  • Storage pull-point comparisons for caking, agglomeration, PSD drift, emitted behavior, package observations, and assay or tracer recovery.

Deliverables

#FormatContents
01PDF reportProtocol, setup, controls, deviations, endpoint tables, and interpretation limits.
02CSV / XLSX datasetsPSD, exposure, imaging, recovery, and stability trend tables.
03Images / videoHigh-speed frames, plume sequences, setup photos, and annotated observations.
Extended deliverables · multi-arm comparability · stability · predicate studies
  • Exposure appendix — Scenario assumptions, concentration-time data, particle sizing, benchmark inputs, and sensitivity outputs.
  • Stability trend pack — Pull-point tables and figures for PSD, caking, plume behavior, package observations, and recovery results.
  • Comparator summary — Side-by-side formulation, powder grade, applicator, or package comparisons with endpoint-specific limits.

QA / QC & data integrity

Each powder spray study includes a QA/QC plan matched to the selected endpoints and powder handling risks. Controls run alongside sample collection to keep particle, imaging, exposure, recovery, and trend data traceable from sample receipt through the final report. ARE Labs documents conditioning events, deviations, and exclusions instead of obscuring them in summary tables.

Device-off backgrounds, chamber blanks, blank fixtures, reference powders, or no-actuation controls selected by endpoint.

Flow meters, balances, particle instruments, imaging scales, environmental sensors, and analytical instruments checked or calibrated before use.

Powder conditioning, humidity, discharge timing, orientation, sampling location, dispersion settings, and recovery procedure recorded per run.

Recovery, carryover, blank correction, matrix effects, and static-loss checks included when chemistry or tracer endpoints require them.

Chain of custody covers powder lots, packages, filters, impactor stages, extracts, raw files, images, calculations, and report tables.

Why ARE Labs

ARE Labs connects technical topics to practical study design, method selection, controlled aerosol work, and reportable evidence without turning technical pages into sales pages.

Reviewed byJamie Balarashti (25 yrs - cascade & inhalation methods) - Weston Schaper (7 yrs - real-time sizing & nanoparticle work)
QualityDocumented study records
900+Studies Performed
17+Years in operation
300+Clients supported

Common questions

These answers address common questions from powder spray, dry powder product, formulation, and package teams: which endpoints to combine, how powder handling is controlled, what determines sample needs, which data are delivered, and where the defined testing scope ends. Most programs require at least one product-specific decision about conditioning, actuation, sampling geometry, or exposure assumptions.

Q.Which powder spray test should I start with?
A.Begin with the decision the study must support. PSD characterizes particle size and respirable fraction, imaging shows release behavior, inhalation assessment evaluates exposure, and stability testing tracks changes during storage.
Q.How is powder handling controlled?
A.The protocol defines conditioning, humidity, handling steps, actuation, orientation, discharge count, and sampling geometry. These controls are important because powder flowability and agglomeration can change quickly.
Q.Can ARE Labs support drug-like dry powder products?
A.Yes, within a defined scope covering aerosol, particle sizing, emitted behavior, and analytical support. Broader CMC, clinical, labeling, biocompatibility, and full submission activities require a separate scope.
Q.What affects sample count and timeline?
A.Sample requirements depend on the number of powder lots, product configurations, conditioning states, endpoints, exposure scenarios, assays, and replicates. For stability programs, requirements also follow the storage pull schedule.
Q.What data will we receive?
A.Deliverables may include a PDF report, CSV/XLSX datasets, PSD curves, concentration time series, high-speed images, exposure calculations, recovery data, trend plots, and QA/QC records.

Standards & guidance

Most powder spray and dry powder product programs are fit-for-purpose because the applicable framework depends on the product's intended use. ARE Labs selects references that match each measurement endpoint and identifies whether the method is accredited, aligned, or conformant, where applicable. The rows below summarize the standards and guidance clusters most often used for particle sizing, imaging investigations, inhalation exposure, and storage-trend studies.

QA & Regulatory - Accredited

ISO 17025

Laboratory competence, calibration traceability, method control, and reporting qualityView standard ->Particle & Aerosol Measurement - Aligned

ISO 13320

Laser diffraction particle sizing principles for dry powder and powder-cloud spectraView standard ->Inhalation & Drug Delivery - Aligned

FDA MDI / DPI / nasal

Inhalation product quality context for drug-like dry powder output and aerodynamic sizingView standard ->QA & Regulatory - Aligned

ICH Q9

Quality-risk framing for powder release investigations and product-change reviewView standard ->Exposure & Safety - Aligned

OSHA PEL / NIOSH REL

Exposure benchmarks used for inhalation-risk support and scenario comparisonsView standard ->Stability - Aligned

ICH Q1A (R2)

Storage-condition and pull-point logic for powder stability and performance driftView standard ->

Related testing services

Test

Particle Size Distribution (PSD) Testing

Quantifies powder particle size, aerodynamic fraction, and respirable fraction for formulation, applicator, exposure, and storage comparisons.Read more ->Test

High-Speed Imaging & Velocimetry

Documents transient powder release, clogging, sputtering, plume direction, and applicator-driven timing changes.Read more ->Test

Inhalation Risk Assessment

Connects measured powder PSD and chamber concentration data to scenario exposure and margin-of-safety review.Read more ->Test

Stability and Accelerated Aging

Tracks caking, agglomeration, PSD drift, package effects, emitted behavior, and recovery across storage pulls.Read more ->